L&G Pharma Breakthrough UCITS ETF (AMS:BIOT)
10.31
-0.01 (-0.09%)
Last updated: Aug 22, 2025
AMS:BIOT Holdings Information
AMS:BIOT is an equity ETF with a total of 42 individual holdings. The top holdings are InnoCare Pharma stock at 4.78%, Alnylam Pharmaceuticals at 4.68%, Xeris Biopharma Holdings at 4.46%, Pharming Group at 3.72%, and Ligand Pharmaceuticals at 3.38%.
Total Holdings
42
Top 10 Percentage
36.26%
Asset Class
Equity
ETF Category
Health Care
Assets
14.27M
PE Ratio
15.69
Sector Allocation
Top 25 Holdings
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | INCPF | InnoCare Pharma Ltd | 4.78% |
2 | ALNY | Alnylam Pharmaceuticals, Inc. | 4.68% |
3 | XERS | Xeris Biopharma Holdings, Inc. | 4.46% |
4 | AMS: PHARM | Pharming Group N.V. | 3.72% |
5 | LGND | Ligand Pharmaceuticals Incorporated | 3.38% |
6 | IONS | Ionis Pharmaceuticals, Inc. | 3.16% |
7 | ONC | BeOne Medicines Ltd. | 3.13% |
8 | INCY | Incyte Corporation | 3.04% |
9 | TYO: 4151 | Kyowa Kirin Co., Ltd. | 2.99% |
10 | KRX: 051910 | LG Chem, Ltd. | 2.92% |
11 | HALO | Halozyme Therapeutics, Inc. | 2.91% |
12 | ZVRA | Zevra Therapeutics, Inc. | 2.86% |
13 | EPA: IPN | Ipsen S.A. | 2.81% |
14 | TYO: 4523 | Eisai Co., Ltd. | 2.81% |
15 | RPRX | Royalty Pharma plc | 2.79% |
16 | NVSN.MX | Novartis AG ADR | 2.75% |
17 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.72% |
18 | JNJ | Johnson & Johnson | 2.68% |
19 | AZN | AstraZeneca PLC | 2.59% |
20 | STO: SOBI | Swedish Orphan Biovitrum AB (publ) | 2.53% |
21 | TYO: 4188 | Mitsubishi Chemical Group Corporation | 2.51% |
22 | CPH: GMAB | Genmab A/S | 2.49% |
23 | TVTX | Travere Therapeutics, Inc. | 2.48% |
24 | UTHR | United Therapeutics Corporation | 2.42% |
25 | PTCT | PTC Therapeutics, Inc. | 2.32% |
As of Aug 20, 2025